Biogen
| Use attributes for filter ! | |
| Number of employees | December 2017 |
|---|---|
| Headquarters | Cambridge |
| Massachusetts | |
| United States | |
| Ceo | Michel Vounatsos |
| Revenue | 12. 27 billion USD (2017) |
| Subsidiaries | Biogen Idec Ltd |
| Biogen Inc. | |
| Biogen Idec GmbH | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 672629 |
About Biogen
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Drug donanemab seen as turning point in dementia fight
Jul 17,2023 10:30 am
... " Donanemab, made by Eli Lilly, works in the same way as lecanemab - developed by companies Eisai and Biogen - when it was proven to slow the disease...
Alzheimer's drug lecanemab hailed as momentous breakthrough
Nov 29,2022 8:50 pm
... The developers - the pharmaceutical companies Eisai and Biogen - plan to begin the approval process in other countries next year...
